The Availability of the Enhanced Liver Fibrosis (ELF) Test Affects the Rate of Diagnosis of Nonalcoholic Steatohepatitis (NASH) With Fibrosis in Patients Referred to Hepatology

NAUnknownINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

December 1, 2022

Study Completion Date

December 1, 2022

Conditions
Fatty LiverNAFLD
Interventions
DIAGNOSTIC_TEST

ELF Test

Patients receive ELF testing (a blood draw) and their hepatologist receives the result within a week.

Trial Locations (1)

66160

RECRUITING

University of Kansas Medical Center, Kansas City

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

University of Kansas Medical Center

OTHER